SUHEUNG CO.,LTD. Logo

SUHEUNG CO.,LTD.

Global manufacturer of capsules and contract manufacturing for pharma/nutraceutical industries.

008490 | KO

Overview

Corporate Details

ISIN(s):
KR7008490005
LEI:
Country:
South Korea
Address:
충청북도 청주시 흥덕구 오송읍 오송생명로 61 -, 청주시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Suheung Co., Ltd. is a global manufacturer specializing in capsules for the pharmaceutical and nutraceutical industries. Established in 1973, the company produces a wide range of empty hard and soft capsules, as well as other solid dosage forms like tablets. Suheung is a vertically integrated enterprise, offering comprehensive contract manufacturing services that cover the entire process from raw material supply to final packaging. As one of the largest capsule suppliers worldwide, the company serves major global markets, emphasizing quality and continuous research and development to deliver solutions for its clients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-25 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 83.3 KB
2025-08-14 00:00
Interim Report
[기재정정]반기보고서 (2025.06)
Korean 5.1 MB
2025-08-13 00:00
Interim Report
반기보고서 (2025.06)
Korean 5.0 MB
2025-05-30 00:00
Governance Information
기업지배구조보고서공시
Korean 1.0 MB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 3.0 MB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 21.0 KB
2025-03-20 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 712.2 KB
2025-03-14 00:00
Audit Report / Information
감사보고서제출
Korean 20.8 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의
Korean 17.8 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 62.1 KB
2025-02-27 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 10.1 KB
2025-02-27 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 373.7 KB
2025-02-27 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 5.4 KB
2025-02-18 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변경
Korean 13.9 KB
2025-02-12 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정
Korean 8.5 KB

Automate Your Workflow. Get a real-time feed of all SUHEUNG CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SUHEUNG CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SUHEUNG CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Tourmaline Bio, Inc. Logo
Develops an anti-IL-6 antibody for cardiovascular, inflammatory, and immune diseases.
United States of America
TRML
TOWA PHARMACEUTICAL CO.,LTD. Logo
Manufactures and markets high-quality, accessible generic drugs for various therapeutic areas.
Japan
4553
Transcode Therapeutics, Inc. Logo
Develops targeted RNA therapies for metastatic cancer using a proprietary nanoparticle delivery platform.
United States of America
RNAZ
Travere Therapeutics, Inc. Logo
Develops therapies for rare kidney and metabolic diseases, with an FDA-approved treatment for IgA nephropathy.
United States of America
TVTX
Traws Pharma, Inc. Logo
Develops oral small-molecule therapies for respiratory viral diseases and cancer.
United States of America
TRAW
TScan Therapeutics, Inc. Logo
Developing TCR-engineered T-cell therapies for solid and hematologic cancers.
United States of America
TCRX
TSUMURA & CO. Logo
A leader in Japanese Kampo herbal medicine, producing prescription and OTC formulations.
Japan
4540
TuHURA Biosciences, Inc./NV Logo
Phase 3 immuno-oncology firm developing therapeutics to overcome cancer therapy resistance.
United States of America
HURA
TURK İLAÇ VE SERUM SANAYİ A.Ş. Logo
Turkish producer of pharmaceuticals, specializing in IV solutions and vaccines for hospitals.
Türkiye
TRILC
Tvardi Therapeutics, Inc. Logo
Developing oral STAT3 inhibitors to treat cancers and fibrosis-driven diseases.
United States of America
TVRD

Talk to a Data Expert

Have a question? We'll get back to you promptly.